It is currently Wed Jul 30, 2014 2:33 pm

News News of Sativex

Site map of Sativex » Forum : Sativex

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Cannabis drug prescriptions for MS patients halted

Image


Patients with Multiple sclerosis (MS), an inflammatory disease that affects the nervous system, might not be prescribed the drug Sativex as distribution has been halted in Scotland due to budget cuts and the awaited approval by the Scottish Medicines Consortium (SMC).

The cannabis-based drug is orally administered by spraying it under the tongue of the patient and promises pain relief where other types of medications have failed.

However, Sativex is an expensive drug to ...
Read more : Cannabis drug prescriptions for MS patients halted | Views : 1579 | Replies : 0


Sativex® approved in the Czech Republic for MS spasticity

Image

GW Pharmaceuticals plc today announces that Sativex® oromucosal spray has been approved in the Czech Republic as a treatment for spasticity due to Multiple Sclerosis (MS).

This approval follows GW's announcement on 22nd March 2011 that the European Mutual Recognition Procedure had successfully completed with all six countries involved recommending approval. The countries involved in the MRP were Germany, Italy, Denmark, Sweden, Austria and the Czech Republic. The Czech Republic is the first of ...
Read more : Sativex® approved in the Czech Republic for MS spasticity | Views : 1591 | Replies : 2


GW Pharma signs Sativex license deal with Novartis

Image

U.K. drug maker GW Pharmaceuticals PLC said it has signed a license deal with Novartis AG to commercialize its cannabis-based multiple sclerosis treatment Sativex in a range of markets including Australia, parts of Asia and Africa.

Under the agreement, GW will get an upfront payment of $5 million and receive a further $28.75 million dependent on certain approvals and commercial milestones.

Novartis will have exclusive rights to sell Sativex in Australia; New Zealand; Asia, ...
Read more : GW Pharma signs Sativex license deal with Novartis | Views : 1366 | Replies : 0


MS drug Sativex wins approval in 6 new markets

Image

GW Pharmaceuticals Plc's pioneering cannabis drug Sativex has been recommended for approval in the six other European countries targeted by the British company and Spanish partner Almirall.

National approvals are now expected in Austria, Czech Republic, Denmark, Germany, Italy and Sweden from mid-2011 onwards, with launches in Denmark, Germany and Sweden likely before the end of 2011, GW said on Tuesday.

The medicine was expected to go on sale in the remaining countries in ...
Read more : MS drug Sativex wins approval in 6 new markets | Views : 1459 | Replies : 1


Sativex for spasticity due to MS launched in Spain

Image

Almirall, S.A. announces that Sativex® is now available to health professionals and patients in the Spanish hospital pharmacies. It is the first specific treatment for spasticity in MS patients who have not responded adequately to other treatments. Sativex® is administered as oromucosal spray enabling flexible dosage, which is particularly appropriate given the variable nature ofspasticity and MS itself.

Evidence from clinical trials shows that Sativex® has a positive impact on spasticity, sleep quality and ...
Read more : Sativex for spasticity due to MS launched in Spain | Views : 1462 | Replies : 0


Sativex?

What's the story with this? I'm seeing that it was developed for ms, but there're only trials in the US for using it to treat cancer pain.
Read more : Sativex? | Views : 2344 | Replies : 10


Are you using Sativex? Tell me about it.

I am writing an article about Sativex for a new US publication, launching in December. If you have experience with Sativex in Canada, please comment here or contact me at: marikane@marikane.com

Thanks very much.
Mari Kane
Read more : Are you using Sativex? Tell me about it. | Views : 2356 | Replies : 1


Sativex, MS cannabis drug yet to take off

Image

GW Pharmaceuticals' pioneering cannabis drug is getting a mixed reception four months into its launch across Britain, its first European market.
A survey of primary care trusts today found several that were not recommending Savitex to multiple sclerosis patients, with many viewing it as “low priority”.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
Read more : Sativex, MS cannabis drug yet to take off | Views : 1536 | Replies : 0


Sativex approved for MS by New Zealand

Image

Cannabis based medicines group GW Pharmaceuticals has had its Sativex treatment for the relief of spasticity in Multiple Sclerosis (MS) approved by the New Zealand regulatory authority.

The mouth spray, which contains two cannabinoids or active ingredients - THC and CBD - is the first cannabinoid medicine derived from whole plant extracts from the cannabis sativa plant...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... geid/1814/
Read more : Sativex approved for MS by New Zealand | Views : 1493 | Replies : 0


Multiple Sclerosis patients denied cannabis spray

Image

A Cannabis-based drug that may relieve symptoms of multiple sclerosis will be denied to Calderdale patients.

NHS Calderdale has confirmed the oral spray Sativex will not be routinely funded for the area's estimated 300 sufferers.

The newly-licensed medicine contains cannabinoids...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
Read more : Multiple Sclerosis patients denied cannabis spray | Views : 1543 | Replies : 0


 

Login  •  Register


Statistics

Total posts 218763 • Total topics 22548 • Total members 14195